Dr. Reddy's Laboratories Limited
RDY
$14.49
$0.140.98%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.87% | 1.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.87% | 1.00% | |||
| Cost of Revenue | -0.64% | 6.23% | |||
| Gross Profit | -4.71% | -2.96% | |||
| SG&A Expenses | -0.21% | 1.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 21.73% | 6.89% | |||
| Total Operating Expenses | -0.46% | 3.61% | |||
| Operating Income | -13.53% | -9.10% | |||
| Income Before Tax | -17.60% | -5.57% | |||
| Income Tax Expenses | -15.16% | -19.20% | |||
| Earnings from Continuing Operations | -18.30% | -0.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 90.36% | 24.32% | |||
| Net Income | -17.51% | -0.63% | |||
| EBIT | -13.53% | -9.10% | |||
| EBITDA | -10.05% | -6.32% | |||
| EPS Basic | -17.50% | -0.70% | |||
| Normalized Basic EPS | -13.59% | -4.81% | |||
| EPS Diluted | -17.51% | -0.65% | |||
| Normalized Diluted EPS | -13.66% | -4.69% | |||
| Average Basic Shares Outstanding | -0.01% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -1.00% | -- | |||